OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
20.09
+0.48 (2.45%)
At close: Aug 13, 2025, 4:00 PM
20.10
+0.01 (0.05%)
Pre-market: Aug 14, 2025, 8:44 AM EDT
OrthoPediatrics Revenue
OrthoPediatrics had revenue of $61.08M in the quarter ending June 30, 2025, with 15.68% growth. This brings the company's revenue in the last twelve months to $220.73M, up 26.08% year-over-year. In the year 2024, OrthoPediatrics had annual revenue of $204.73M with 37.65% growth.
Revenue (ttm)
$220.73M
Revenue Growth
+26.08%
P/S Ratio
2.12
Revenue / Employee
$392,763
Employees
562
Market Cap
503.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 204.73M | 56.00M | 37.65% |
| Dec 31, 2023 | 148.73M | 26.44M | 21.62% |
| Dec 31, 2022 | 122.29M | 24.24M | 24.72% |
| Dec 31, 2021 | 98.05M | 26.97M | 37.95% |
| Dec 31, 2020 | 71.08M | -1.47M | -2.03% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
KIDS News
- 8 days ago - OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance - GlobeNewsWire
- 8 days ago - OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics - GlobeNewsWire
- 9 days ago - OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference - GlobeNewsWire
- 13 days ago - OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case - GlobeNewsWire
- 22 days ago - OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025 - GlobeNewsWire
- 4 weeks ago - Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products - GlobeNewsWire
- 3 months ago - OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting - GlobeNewsWire